Tuesday, November 30, 2021

Latest:

New evidence supports a cancer-promoting role for enzyme MAPK6
Making safe maternal healthcare a possibility in The Gambia
COPD: what you need to know
Research staff 101: Fostering curiosity, creativity, and community
Tips for Diabetic Foot Care

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

MAPK4

From The Labs

New evidence supports a cancer-promoting role for enzyme MAPK6

November 30, 2021November 30, 2021 Ana Rodríguez 0 Comments cancer growth, MAPK4, MAPK6, mTOR inhibitors, Research

The findings suggest that therapies that interfere with MAPK6 activity may offer an effective cancer treatment approach.

From The Labs

Targeting MAPK4 emerges as a promising therapy for prostate cancer

February 23, 2021February 23, 2021 Ana Rodríguez 0 Comments Akt pathway, androgen receptor, cancer therapy, castration-resistant prostate cancer, MAPK4, Prostate Cancer, Research

Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.

From the Labs features a visualization of a novel approach to study gene function in the fruit fly. Image courtesy of the study authors/Cell Reports, 2021.